•  
  •  
  •  
  •  

2026-08-11 17:38:55

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lemon Tree Hotels signs Second hotel in Mcleodganj
  • Axis Mutual Fund launches Axis Nifty Energy Index Fund & Axis Nifty Energy ETF NFOs offering exposure to India's evolving capital energy ecosystem
  • Websol Energy Q1FY27 Revenue up 70% YoY at Rs 373 crore; Company Prepays Entire IREDA Term Loan
  • CPPIB to Invest ₹3,000 Crore in Prestige Estates' Hospitality Arm PHVL for Up to 28% Stake
  • Krystal Integrated Services Consortium Secures ₹740 Crore Urban Wastewater Contracts in Maharashtra

Keywords Selected:  USA

Stock Report

  • Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States
  • Elgi Compressors USA Inc receives tariff refund of $2.68 Mn
  • 3i Infotech Inc., USA receives order worth Rs. 1.47 crore
  • Blue Cloud Softech Solutions Ltd - USA Executes Five-Year Master Services Agreement for AI Services with SpaceX International Ltd, MY
  • Aurobindo Pharma USA Inc completes acquisition of Lannett Company, Inc
  • Waaree Energies' Clarifies U.S. Customs Determination
  • Glenmark Pharmaceuticals Inc., USA launches Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial
  • Lupin Pharmaceuticals, Inc, USA enters into settlement agreement with Humana Inc
  • Unichem Pharmaceuticals (USA) Issues Voluntary Recall of Buspirone Hydrochloride Tablets
  • 3i Infotech Inc., USA receives order worth Rs. 2.76 crores
  • 3i Infotech Inc., USA receives order worth approx. Rs. 1.63 crores
  • Glenmark Pharmaceuticals announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS® in the U.S.
  • Glenmark Therapeutics Inc., USA launches Fluticasone Propionate Nasal Spray USP, 50 mcg per spray (OTC)
  • 3i Infotech Inc., USA receives order worth Rs. 2.21 crores
  • Glenmark Pharmaceuticals Inc., USA to launch Sodium Phosphates Injection USP, 15 mM P/5 mL, 45 mM P/15 mL and 150 mM P/50 mL (3 mM P/mL) Single-Dose Vials
  • LT Foods Secures Major Relief in U.S. Countervailing Duty Review
  • Powerhouse Engines Selects Ramco Systems to Transform Engine MRO Operations
  • Lupin Launches Authorized Generic Version of Ravicti® in the United States
  • Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP
  • Lupin gets one observation from USFDA for Somerset, New Jersey manufacturing facility
  • Emmforce Autotech Ltd secures prestigious order worth Rs. 10.50 crores
  • Optiemus Infracom and Ordinary Theory USA announce JV to Manufacture & Market 'Made in India' Smart Enterprise Hardware & Industrial Solutions
  • Waaree Energies' Continued Commitment to U.S. Manufacturing and Regulatory Compliance
  • Hexaware Technologies Ltd - Update on U.S. H1B Visa Regulation Changes

Latest Post

  • Lemon Tree Hotels signs Second hotel in Mcleodganj
  • Axis Mutual Fund launches Axis Nifty Energy Index Fund & Axis Nifty Energy ETF NFOs offering exposure to India's evolving capital energy ecosystem
  • Websol Energy Q1FY27 Revenue up 70% YoY at Rs 373 crore; Company Prepays Entire IREDA Term Loan
  • CPPIB to Invest ₹3,000 Crore in Prestige Estates' Hospitality Arm PHVL for Up to 28% Stake
  • Krystal Integrated Services Consortium Secures ₹740 Crore Urban Wastewater Contracts in Maharashtra


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025